Cholesterol in Alzheimer's disease and tauopathy

Annals of the New York Academy of Sciences

Volumn 977, Issue , 2002, Pages 367-375

  Burns, Mark ^a   Duff, Karen ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Alzheimer's disease (AD); A ; Cholesterol; Niemann Pick; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL TISSUE; CELL PROTECTION; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; DISEASE MODEL; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPIDOSIS; MOUSE; NEUROFIBRILLARY TANGLE; NIEMANN PICK DISEASE; NONHUMAN; PEPTIDE ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RISK FACTOR; TAUOPATHY;

ANIMALIA;

EID: 0036452144     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04839.x     Document Type: Conference Paper

References (38)

1. Jarvik, G.P., E.M. Wijsman, W.A. Kukull et al. 1995. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: A case-control study. Neurology 45: 1092-1096.
2. Notkola, I.L., R. Sulkava, J. Pekkanen et al. 1998. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17: 14-20.
3. Evans, R.M., C.L. Emsley, S. Gao et al. 2000. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population-based study of African Americans. Neurology 54: 240-242.
4. Launer, L.J., L.R. White, H. Petrovitch et al. 2001. Cholesterol and neuropathologic markers of AD: A population-based autopsy study. Neurology 57: 1447-1452.
5. Wolozin, B., W. Kellman et al. 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57: 1439-1443.
6. Jick, H., G.L. Zornberg, S.S. Jick et al. 2000. Statins and the risk of dementia. Lancet 356: 1627-1631.
7. Anderson, M., P.G. Elmberger, C. Edlund et al. 1990. Rates of cholesterol, ubiquinone, dolichol, and dolichyl-P biosynthesis in rat brain slices. FEBS Lett. 269: 15-18
8. Edmond, J., R.A. Korsak, J.W. Morrow et al. 1991. Dietary cholesterol and the origin of cholesterol in the brain of developing rats. J. Nutr. 121: 1323-1330.
9. Zhang, W.Y., P.M. Gaynor & H.S. Kruth. 1996. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J. Biol. Chem. 271: 28641-28646.
10. Mahley, R.W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
11. Bjorkhem, I., D. Lutjohann, U. Diczfalusy et al. 1998. Cholesterol homeostasis in human brain: Turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39: 1594-1600.
12. Jurevics, H. & P. Morell. 1995. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64: 895-901.
13. Mauch, D.H., K. Nagler, S. Schumacher et al. 2001. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294: 1354-1357.
14. Simons, K. & E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387: 569-572.
15. Fra, A.M., E. Williamson et al. 1994. Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J. Biol. Chem. 269: 30745-30748.
16. Danielsen, E.M. & B. van Deurs. 1995. A transferrin-like GPI-linked iron-binding protein in detergent-insoluble noncaveolar microdomains at the apical surface of fetal intestinal epithelial cells. J. Cell Biol. 131: 939-950.
17. Simons, K. & E. Ikonen. 2000. How cells handle cholesterol. Science 290: 1721-1726.
18. Rothberg, K.G., J.E. Heuser, W.C. Donzell et al. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682.
19. Lee, S.J., U. Liyanage, P.E. Bickel et al. 1998. A detergent-insoluble membrane compartment contains Aβ in vivo. Nat. Med. 4: 730-734.
20. Simons, M., P. Keller, B. De Strooper et al. 1998. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 95: 6460-6464.
21. Bodovitz, S. & W.L. Klein. 1996. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271: 4436-4440.
22. Wharle, S., P. Das et al. 2002. Cholesterol-dependent [gamma]-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9: 11-23.
23. Puglielli, L., G. Konopka, E. Pack-Chung et al. 2001. Acyl-coenzyme A:cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat. Cell Biol. 3: 905-912.
24. Sparks, D.L., S.W. Scheff, J.C. Hunsaker et al. 1994. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126: 88-94.
25. Howland, D.S., S.P. Trusko, M.J. Savage et al. 1998. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J. Biol. Chem. 273: 16576-16582.
26. Refolo, L.M., B. Malester, J. LaFrancois et al. 2000. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7: 321-331.
27. Refolo, L.M., M.A. Pappolla, J. LaFrancois et al. 2001. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8: 890-899.
28. Fassbender, K., M. Simons, C. Bergmann et al. 2001. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98: 5856-5861.
29. Mori, T., D. Paris, T. Town et al. 2001. Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice. J. Neuropathol. Exp. Neurol. 60: 778-785.
30. Avdulov, N.A., S.V. Chochina, U. Igbavboa et al. 1997. Lipid binding to amyloid beta-peptide aggregates: Preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J. Neurochem. 69: 1746-1752.
31. Suzuki, K., C.C. Parker, P.G. Pentchev et al. 1995. Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol. 89: 227-238.
32. Manni, M.E., R. Cescato & P.A. Paganetti. 1998. Lack of beta-amyloid production in M19 cells deficient in site 2 processing of the sterol regulatory element binding proteins. FEBS Lett. 427: 367-370.
33. Xie, C., S.D. Turley, P.G. Pentchev & J.M. Dietschy. 1999. Cholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein. Am. J. Physiol. 276: E336-E344.
34. Xie, C., S.D. Turley & J.M. Dietschy. 1999. Cholesterol accumulation in tissues of the Niemann-Pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ. Proc. Natl. Acad. Sci. U.S.A. 96: 11992-11997.
35. Sparks, D.L., J.C. Hunsaker III, S.W. Scheff et al. 1990. Cortical senile plaques in coronary artery disease, aging, and Alzheimer's disease. Neurobiol. Aging 11: 601-607.
36. Sparks, D.L., S.W. Scheff, H. Liu et al. 1995. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J. Neurol. Sci. 131: 162-169.
37. Prince, M., M. Cullen & A. Mann. 1994. Risk factors for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial. Neurology 44: 97-104.
38. Launer, L.J., K. Masaki, H. Petrovitch et al. 1995. The association between midlife blood pressure levels and late-life cognitive function: The Honolulu-Asia Aging Study. JAMA 274: 1846-1851.